Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

Population screening for liver fibrosis: towards early diagnosis and intervention for chronic liver diseases

(2021) Pere Ginès et al.   HEPATOLOGY

Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

(2021) Ditlev Nytoft Rasmussen et al.   JOURNAL OF HEPATOLOGY

Long‐term prognosis of patients with alcohol‐related liver disease or non‐alcoholic fatty liver disease according to metabolic syndrome or alcohol use

(2021) Marie Decraecker et al.   LIVER INTERNATIONAL

Non‐invasive tests for liver fibrosis in NAFLD: Creating pathways between primary healthcare and liver clinics

(2020) Laurent Castera   LIVER INTERNATIONAL

Is there an association between commonly employed biomarkers of liver fibrosis and liver stiffness in the general population?

(2020) Francesco Giuseppe Foschi et al.   Annals of Hepatology

Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease

(2020) Salvatore Petta et al.   Clinical Gastroenterology and Hepatology

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

(2020) Beth A. Davison et al.   JOURNAL OF HEPATOLOGY

Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease

(2020) Margarita Papatheodoridi et al.   JOURNAL OF HEPATOLOGY

Non-Invasive Assessment of Liver Disease in Patients with NAFLD

(2019) Laurent Castera et al.   GASTROENTEROLOGY

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2019) Peter J. Eddowes et al.   GASTROENTEROLOGY

The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials

(2019) Arun J. Sanyal et al.   HEPATOLOGY

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

(2019) Ankur Srivastava et al.   JOURNAL OF HEPATOLOGY

Noninvasive tests accurately identify advanced fibrosis due to NASH : Baseline data from the STELLAR trials

(2019) Quentin M. Anstee et al.   HEPATOLOGY

Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver Disease

(2019) Hannes Hagström et al.   GASTROENTEROLOGY

Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia

(2019) Miquel Serra-Burriel et al.   JOURNAL OF HEPATOLOGY

Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes

(2019) Fernando Bril et al.   DIABETES CARE

Cost‐effectiveness of non‐invasive screening for alcohol‐related liver fibrosis

(2019) Lars Asphaug et al.   HEPATOLOGY

Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease

(2019) Sarah Shili‐Masmoudi et al.   LIVER INTERNATIONAL

High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study

(2018) Llorenç Caballería et al.   Clinical Gastroenterology and Hepatology

Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease

(2018) Maja Thiele et al.   GASTROENTEROLOGY

Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies

(2018) Laura Pimpin et al.   JOURNAL OF HEPATOLOGY

Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study

(2018) Elliot B Tapper et al.   BMJ-British Medical Journal

Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study

(2018) Elliot B Tapper et al.   BMJ-British Medical Journal

Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study

(2018) Núria Fabrellas et al.   PLoS One

Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016

(2018) Donghee Kim et al.   GASTROENTEROLOGY

Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests

(2018) Jack W O’Sullivan et al.   BMJ-British Medical Journal

Active Surveillance for Low-Risk Cancers — A Viable Solution to Overtreatment?

(2017) Megan R. Haymart et al.   NEW ENGLAND JOURNAL OF MEDICINE

Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis

(2016) Maja Thiele et al.   GASTROENTEROLOGY

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease

(2016) Jérôme Boursier et al.   JOURNAL OF HEPATOLOGY

The benefits of screening–and its harms

(2016) Minna Johansson et al.   LANCET

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography

(2015) D. J. Harman et al.   BMJ Open

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

(2011) Vincent Wai-Sun Wong et al.   GUT

Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years

(2010) D. Roulot et al.   GUT